These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15971304)

  • 1. Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO).
    Mayer R; Mock U; Jäger R; Pötter R; Vutuc C; Eiter H; Krugmann K; Hammer J; Hirn B; Hawliczek R; Knocke-Abulesz TH; Lukas P; Nechville E; Pakisch B; Papauschek M; Raunik W; Rhomberg W; Sabitzer H; Schratter-Sehn A; Sedlmayer F; Wedrich I; Auberger T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S24-8. PubMed ID: 15971304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of MedAustron.
    Griesmayer E; Auberger T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S202-5. PubMed ID: 15971342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The med AUSTRON/OGRO patterns of care study on radiotherapy indications in Austria.
    Mock U; Mayer R; Potter R; Jäger R; Vutuc C; Eiter H; Hammer J; Hawliczek R; Hirn B; Knocke-Abulesz TH; Kogelnik HD; Lukas P; Nechville E; Pakisch B; Papauschek M; Ing Raunik W; Rhomberg W; Sabitzer H; Schratter-Sehn A; Sedlmayer F; Wedrich I; Auberger T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S29-34. PubMed ID: 15971305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
    Orecchia R; Fossati P; Rossi S
    Tumori; 2009; 95(2):169-76. PubMed ID: 19579862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of the "ETOILE" project for a French hadrontherapy centre.
    Bajard M; De Conto JM; Remillieux J;
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S211-5. PubMed ID: 15971344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical aspects of the National Centre For Oncological Hadrontherapy (CNAO-Centro Nazionale Adroterapia Oncologica) in Italy.
    Krengli M; Orecchia R
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S21-3. PubMed ID: 15971303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol.
    Pommier P; Zucca L; Näslund I; Auberger T; Combs SE; François G; Heeren G; Rochat J; Perrier L
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S183-5. PubMed ID: 15971339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards offline PET monitoring of proton therapy at MedAustron.
    Meißner H; Fuchs H; Hirtl A; Reschl C; Stock M
    Z Med Phys; 2019 Feb; 29(1):59-65. PubMed ID: 29858131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the clinical work at Hyogo.
    Hishikawa Y; Oda Y; Mayahara H; Kawaguchi A; Kagawa K; Murakami M; Abe M
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S38-40. PubMed ID: 15971307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A "one-day survey": as a reliable estimation of the potential recruitment for proton- and carbon- ion therapy in France.
    Baron MH; Pommier P; Favrel V; Truc G; Balosso J; Rochat J
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S15-7. PubMed ID: 15974560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of the economic sustainability of Hadron therapy: the real cost of setting up and operating a Hadron facility.
    Vanderstraeten B; Verstraete J; De Croock R; De Neve W; Lievens Y
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):152-60. PubMed ID: 24725698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of European proton and carbon ion therapy centers assessed by the EORTC facility questionnaire.
    Weber DC; Abrunhosa-Branquinho A; Bolsi A; Kacperek A; Dendale R; Geismar D; Bachtiary B; Hall A; Heufelder J; Herfarth K; Debus J; Amichetti M; Krause M; Orecchia R; Vondracek V; Thariat J; Kajdrowicz T; Nilsson K; Grau C
    Radiother Oncol; 2017 Aug; 124(2):185-189. PubMed ID: 28764925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COST-ENLIGHT strategic workshop on hadron (particle) therapy, CERN, Geneva, 3-4 May 2007.
    Taylor RE
    Br J Radiol; 2008 Mar; 81(963):169-71. PubMed ID: 18208851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
    Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
    Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENLIGHT: European network for Light ion hadron therapy.
    Dosanjh M; Amaldi U; Mayer R; Poetter R;
    Radiother Oncol; 2018 Jul; 128(1):76-82. PubMed ID: 29625810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conception of heavy ion beam therapy at Heidelberg University (HICAT)].
    Heeg P; Eickhoff H; Haberer T
    Z Med Phys; 2004; 14(1):17-24. PubMed ID: 15104006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Particle beam radiotherapy].
    Saitoh J; Nakano T
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2546-9. PubMed ID: 25596047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment planning for carbon ion radiotherapy in Germany: review of clinical trials and treatment planning studies.
    Jäkel O; Krämer M; Schulz-Ertner D; Heeg P; Karger CP; Didinger B; Nikoghosyan A; Debus J
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S86-91. PubMed ID: 15971317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
    Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.